Species differences in hydrolase activities toward OT-7100 responsible for different bioavailability in rats, dogs, monkeys and humans

By Kuribayashi S.   Ueda N.   Naito S.   Yamazaki H.   Kamataki T.  

Xenobiotica, Vol. 36, Iss. 4, 2006-04 ,pp. : 301-314

Informa Healthcare

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 391-402

Informa Healthcare

Access to resources Recommend Favorite

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys

By Jones Andrew J.S.   Papac Damon I.   Chin Edward H.   Keck Rodney   Baughman Sharon A.   Lin Yvonne S.   Kneer Johannes   Battersby John E.  

Glycobiology, Vol. 17, Iss. 5, 2007-05 ,pp. : 529-540

Oxford University Press

Access to resources Recommend Favorite

CYP2C76-mediated species difference in drug metabolism: A comparison of pitavastatin metabolism between monkeys and humans

By Uno Y.   Kumano T.   Kito G.   Nagata R.   Kamataki T.   Fujino H.  

Xenobiotica, Vol. 37, Iss. 1, 2007-01 ,pp. : 30-43

Informa Healthcare

Access to resources Recommend Favorite

Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs

By Nishimuta Haruka   Nakagawa Tetsuya   Nomura Naruaki   Yabuki Masashi  

Xenobiotica, Vol. 43, Iss. 11, 2013-11 ,pp. : 948-955

Informa Healthcare

Access to resources Recommend Favorite